200 related articles for article (PubMed ID: 18559618)
1. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
2. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
[TBL] [Abstract][Full Text] [Related]
4. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
[TBL] [Abstract][Full Text] [Related]
5. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
Higashiyama S
Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
[TBL] [Abstract][Full Text] [Related]
6. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
8. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells.
Tanida S; Joh T; Itoh K; Kataoka H; Sasaki M; Ohara H; Nakazawa T; Nomura T; Kinugasa Y; Ohmoto H; Ishiguro H; Yoshino K; Higashiyama S; Itoh M
Gastroenterology; 2004 Aug; 127(2):559-69. PubMed ID: 15300588
[TBL] [Abstract][Full Text] [Related]
10. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
12. The carboxyl-terminal fragment of pro-HB-EGF reverses Bcl6-mediated gene repression.
Kinugasa Y; Hieda M; Hori M; Higashiyama S
J Biol Chem; 2007 May; 282(20):14797-806. PubMed ID: 17392284
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.
Nanba D; Mammoto A; Hashimoto K; Higashiyama S
J Cell Biol; 2003 Nov; 163(3):489-502. PubMed ID: 14597771
[TBL] [Abstract][Full Text] [Related]
14. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane.
Hieda M; Isokane M; Koizumi M; Higashi C; Tachibana T; Shudou M; Taguchi T; Hieda Y; Higashiyama S
J Cell Biol; 2008 Feb; 180(4):763-9. PubMed ID: 18299347
[TBL] [Abstract][Full Text] [Related]
15. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase (MAPK) regulates leukotriene D4-induced HB-EGF and ADAM12 expression in human airway smooth muscle cells.
Kumasawa F; Hashimoto S; Mizumura K; Takeshita I; Onose A; Jibiki I; Maruoka S; Gon Y; Kobayashi T; Takahashi N
Asian Pac J Allergy Immunol; 2013 Mar; 31(1):58-66. PubMed ID: 23517395
[TBL] [Abstract][Full Text] [Related]
17. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
[TBL] [Abstract][Full Text] [Related]
18. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
19. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
[TBL] [Abstract][Full Text] [Related]
20. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
